Centaurus Financial’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,203
Closed -$517K 655
2019
Q3
$517K Sell
5,203
-30
-0.6% -$2.85K 0.08% 258
2019
Q2
$484K Buy
5,233
+4,551
+667% +$432K 0.08% 271
2019
Q1
$7.23K Buy
682
+553
+429% +$48.4K 0.04% 305
2018
Q4
$2 Buy
129
+125
+3,125% +$9.23K 0.01% 436
2018
Q3
$391 Sell
4
-7,199
-100% -$636K 0.07% 274
2018
Q2
$572K Buy
7,203
+4,985
+225% +$414K 0.08% 272
2018
Q1
$198K Sell
2,218
-6,492
-75% -$623K 0.05% 329
2017
Q4
$909K Buy
+8,710
New +$983K 0.24% 111

Other funds holding CELG

Centaurus Financial's CELG Position: Q4 2019 in Review

Centaurus Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,203 shares — an estimated $517K sold.

Centaurus Financial first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $909K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Centaurus Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Centaurus Financial sold 5,203 Celgene Corp shares in Q4 2019, an estimated $517K.
  • Centaurus Financial first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • Centaurus Financial's Celgene Corp position peaked at $909K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Centaurus Financial's 13F filing for Q4 2019, filed 12 Feb 2020.